WHO to decide today on Covaxin approval

WHO to decide today on Covaxin approval

A health worker administers vaccine dose at a Mumbai college. PTI

Tribune News Service

New Delhi, October 25

The World Health Organisation’s technical advisory group will meet on Tuesday to consider emergency use listing of India’s indigenous Covid vaccine Covaxin.

The WHO’s chief scientist Soumya Swaminathan said, “The WHO has been working closely with Bharat Biotech to complete the dossier.”

Swaminathan said the WHO’s goal was to have a broad portfolio of vaccines approved for emergency use and to expand access to populations everywhere.

Bharat Biotech, the Covaxin manufacturer, has been submitting data to the WHO on a rolling basis and submitted additional information at the WHO’s request on September 27.

WHO experts have reviewed the information available and Bharat Biotech is learnt to have addressed most of the queries raised by the world body. Covaxin has been developed and produced in India and several countries have expressed interest in the vaccine with India considering exports of surplus stocks once domestic production increases. So far, the WHO has included six vaccines in its EUL. These are Pfizer, Johnson and Johnson, SII-AstraZeneca, Moderna, Sinopharm and Sinovac.

Bharat Biotech, the makers of Covaxin, said as responsible manufacturers with past approvals to other vaccines, the firm was working with the WHO to obtain EUL at the earliest. The approval for Covaxin would make travel for Indians inoculated with the shot and others easier considering Covaxin has not gained approvals from national regulators of some countries, including of the EU and the UK.

All data given: Biotech

Biotech chairman Krishna Ella said all papers required for considering approval to Covaxin had been given.

$50 mn vaccine pact

A US firm and Hyderabad’s Biological E signed a $50 mn pact to expand Covid vaccine manufacturing. back page

  • 14,306 fresh cases
  • TOTAL DEATHS: 4,54,712
  • ACTIVE CASES 1,67,695
  • 443 deaths in 24 hours

Tribune Shorts


View All